Skip to main content

William Raymond Herzog

Clinical Associate in the Department of Medicine
Medicine, Cardiology

Selected Grants


Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2019 - 2025

HEART-FID

Clinical TrialPrincipal Investigator · Awarded by American Regent · 2020 - 2023

Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity

Clinical TrialPrincipal Investigator · Awarded by Novo Nordisk, Inc. · 2019 - 2025

HEART-FID

Clinical TrialPrincipal Investigator · Awarded by American Regent · 2020 - 2023

A Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized Subjects with COVID-19

Clinical TrialPrincipal Investigator · Awarded by Suzhou Kintor Pharmaceuticals, Inc. · 2022 - 2022

DIAMOND

Clinical TrialPrincipal Investigator · Awarded by Relypsa, Inc. · 2020 - 2022

cvMOBIUS

Clinical TrialPrincipal Investigator · Awarded by Amgen, Inc. · 2020 - 2021

Care OptimizatioN through PatieNt and hospital Engagement Clinical Trial for Heart Failure

Clinical TrialPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2018 - 2021

CHAMP-HF

ResearchPrincipal Investigator · Awarded by Novartis Pharmaceuticals Corporation · 2016 - 2020

TACT2

Clinical TrialPrincipal Investigator · Awarded by Mount Sinai Medical Center · 2019 - 2019